• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 9, Issue 2
  3. Author

Online ISSN: 2515-8260

Volume9, Issue2

MDCT imaging features with the histopathological diagnosis of carcinoma esophagus

    Dr. Rashwin Pinto, Dr. Pradeep Kumar CN, Dr. Rinu Pious, Dr. Lohith K, Dr. Supriya AS

European Journal of Molecular & Clinical Medicine, 2022, Volume 9, Issue 2, Pages 2463-2472

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Early oesophageal cancer has shown a good 5-year survival rate of 57%-78%. Its high mortality rate makes it a major concern. Overall survival rate is 62.5% at 1 year, 42.4% at 2 years and 30% at 5 years. The prognosis is poor in locally advanced diseases and worse in cases with distant metastasis. Squamous cell carcinomas (SCCs) and adenocarcinomas are the most common oesophageal cancers. Patients with the signs and symptoms relating to dysphagia, weight loss, and/or hematemesis were referred from various Departments. Out of all these patients, 78 patients were selected on the basis of histopathological examination (HPE) report showing the confirmed presence of carcinoma of the esophagus. All the patients with upper third growths (14 patients, 24.6%) had squamous carcinoma while 25 out of 28 patients (44%) had middle third growths had squamous carcinoma and 18 out of 36 patients (31%) with lower third growths had SCC. Adenocarcinoma was observed to be seen maximum in lower third location (85.7%). Squamous cell carcinoma was observed to be seen maximum in the middle third location (43.9%) followed by lower third location (31.6%). Adenocarcinoma was observed to be seen maximum in lower third location (85.7%). Squamous cell carcinoma was observed to be seen maximum in middle third location (43.9%) followed by lower third location (31.6%).
Keywords:
    MDCT histopathological diagnosis carcinoma esophagus
  • PDF (877 K)
  • XML
(2022). MDCT imaging features with the histopathological diagnosis of carcinoma esophagus. European Journal of Molecular & Clinical Medicine, 9(2), 2463-2472.
Dr. Rashwin Pinto, Dr. Pradeep Kumar CN, Dr. Rinu Pious, Dr. Lohith K, Dr. Supriya AS. "MDCT imaging features with the histopathological diagnosis of carcinoma esophagus". European Journal of Molecular & Clinical Medicine, 9, 2, 2022, 2463-2472.
(2022). 'MDCT imaging features with the histopathological diagnosis of carcinoma esophagus', European Journal of Molecular & Clinical Medicine, 9(2), pp. 2463-2472.
MDCT imaging features with the histopathological diagnosis of carcinoma esophagus. European Journal of Molecular & Clinical Medicine, 2022; 9(2): 2463-2472.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 27
  • PDF Download: 34
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus